Delivery Order SPE2DB22D3016-SPE2DB25FBKN1
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,668.46 to AmerisourceBergen Drug Corp for XHANCE 93 MCG Nasal Spray (16ML) on August 8, 2025, with completion scheduled for August 11, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation to the pharmaceutical distributor's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical supplier within the federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,724.52 to AmerisourceBergen Drug Corp for Xhance 93 mcg nasal spray (16mL) on November 7, 2025, with completion targeted for November 10, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen is a major pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $2,855.22 to AmerisourceBergen Drug Corp for XHANCE 93 microgram nasal spray (16 milliliters) on June 18, 2025, with an ultimate completion date of June 20, 2025. This firm fixed price, non-set-aside contract is being performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for Xhance 93 micrograms nasal spray (16 milliliters) with a ceiling value of $3,221.73. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of November 5, 2025, and performance at the vendor's Conshohocken, Pennsylvania location. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $16,960.28 to AmerisourceBergen Drug Corp for XHANCE 93 MCG Nasal Spray (16ML) on November 12, 2025, with an ultimate completion date of November 13, 2025. This competitively awarded, firm fixed price contract utilizes no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $7,662.60 to AmerisourceBergen Drug Corp for Xhance 93 mcg nasal spray (16ml) on November 3, 2025, with an ultimate completion date of November 4, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a $16,843.25 delivery order to AmerisourceBergen Drug Corp for Xhance 93 mcg nasal spray (16 mL) on December 5, 2025, with an ultimate completion date of December 8, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The order will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Xhance 93 microgram nasal spray in 16-milliliter units. This is a firm fixed-price contract with a ceiling value of $1,241.25 and an ultimate completion date of November 12, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $12,134.11 to supply Xhance 93 MCG nasal spray (16 mL units) with an ultimate completion date of September 18, 2025. This non-competitive delivery order utilizes firm fixed pricing and was awarded on September 17, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under a larger indefinite delivery contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,734.74 to AmerisourceBergen Drug Corp for Xhance 93 mcg nasal spray (16 ml) on December 10, 2025, with an ultimate completion date of December 11, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate office location. This delivery...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBKN1Delivery Order
The Defense Logistics Agency awarded a $1,351.87 firm fixed-price delivery order to AmerisourceBergen Drug Corp for XHANCE 93 mcg nasal spray (16 ml), with an ultimate completion date of September 23, 2025. This is a non-set-aside competitively awarded contract supporting federal medical procurement needs. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for military and veteran healthcare systems. This delivery order falls within AmerisourceBergen's comprehensive pharmaceutical supply portfolio with the DLA, which encompasses brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The SPE2DX prime vendor contract serves as a global pharmaceutical support vehicle enabling the company to supply military healthcare programs worldwide through the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The contract demonstrates AmerisourceBergen's capability to fulfill federal medical supply requirements through open competition, with individual delivery orders ranging from minimal values to substantial orders exceeding $45,000.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 9/22/25 |